3 not yet recruiting, 1 completed. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Not yet recruiting 3, Completed 1 |
| Phase 2 | 2 | Not yet recruiting 2 |
Follow Temozolomide (TMZ): new trials by email Literature Review of Temozolomide (TMZ) trials Research Report on Temozolomide (TMZ)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma Tris-CAR-T cell injection, Ommaya reservoir implantation, Temozolomide (TMZ) - Newly Diagnosed Glioblastoma, IDH-wildtype | Phase 2 / Phase 3 | Not yet recruiting | Beijing Tiantan Hospital | 60 | 2026-10-15 | 2026-10-14 |
| TRINITY TRIAL; Trial Of PRRT Plus CAPTEM Vs CAPTEM Alone In Well Differentiated GEP NETS Capecitabine, Temozolomide (TMZ), Lutetium Lu 177 Dotatate - Gastroenteropancreatic Neuroendocrine Tumors | Phase 3 | Not yet recruiting | Tata Memorial Hospital | 123 | 2026-10-11 | 2026-11-02 |
| Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer Intensity-Modulated Radiation Therapy, Hypofractionated Radiation Therapy, Temozolomide (TMZ) - Advanced Glioblastoma | Phase 2 / Phase 3 | Not yet recruiting | Alliance for Clinical Trials in Oncology | 422 | 2026-06-10 | 2026-05-26 |
| A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma Allovectin-7®, Dacarbazine (DTIC), Temozolomide (TMZ) - Metastatic Melanoma | Phase 3 | Completed | Vical | 390 | 2006-10-01 | 2013-09-13 |
Gastro-enteropancreatic neuroendocrine tumor (1) · Glioblastoma (1) · Melanoma (1) · Neoplasm Metastasis (1)
Alliance for Clinical Trials in Oncology (1) · Beijing Tiantan Hospital (1) · Tata Memorial Hospital (1) · Vical (1)
Belgium (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Switzerland (1) · Turkey (Türkiye) (1) · United States (1)
Linda Strause, PhD (1) · Priya Kumthekar, MD (1) · Tao Jiang, MD, PhD (1) · Wei Zhang, MD, PhD (1) · Yoshie Umemura, MD, MS (1)